Protagonist Therapeutics PTGX

€ 43.10 0.34%

Quartalsbericht 2024-Q2
hinzugefügt 06.08.2024

Andere Aktien der Branche "Pharmaeinzelhändler"

Name	Preis	% 24h	Marktkapitalisierung	Börse	Land
Sorrento Therapeutics SRNE	$ 0.27	-29.58 %	$ 126 M	Nasdaq Global Select Market	USA
ContraFect Corporation CFRX	$ 1.47	-5.16 %	$ 5.39 M	Nasdaq Capital Market	USA
Orchard Therapeutics plc ORTX	$ 4.93	1.02 %	$ 90.8 M	Nasdaq Global Select Market	Britain
Coherus BioSciences CHRS	$ 0.68	-5.71 %	$ 64 M	Nasdaq Global Market	USA
Advaxis ADXS	$ 0.31	-9.65 %	$ 45.9 M	Nasdaq Capital Market	USA
Heat Biologics, Inc. HTBX	$ 3.93	-5.76 %	$ 99.8 M	Nasdaq Capital Market	USA
La Jolla Pharmaceutical Company LJPC	$ 6.2	-	$ 154 M	Nasdaq Capital Market	USA
Zymeworks ZYME	$ 6.42	-	$ 404 M	NYSE	Canada
Checkmate Pharmaceuticals CMPI	$ 10.5	-	$ 231 M	Nasdaq Global Market	USA
Kadmon Holdings, Inc. KDMN	$ 9.5	-	$ 1.7 B	Nasdaq Global Select Market	USA
BioDelivery Sciences International BDSI	$ 2.58	-4.8 %	$ 255 M	Nasdaq Global Select Market	USA
Zosano Pharma Corporation ZSAN	$ 0.56	7.23 %	$ 2.72 M	Nasdaq Global Select Market	USA
Ayala Pharmaceuticals AYLA	$ 0.5	-	$ 7.46 M	Nasdaq Global Market	Israel
Acceleron Pharma Inc. XLRN	$ 179.68	-	$ 10.9 B	Nasdaq Global Market,SPB	USA
Albireo Pharma ALBO	$ 44.15	-0.23 %	$ 916 M	Nasdaq Capital Market	USA
Stealth BioTherapeutics Corp MITO	$ 0.32	-	$ 23.9 M	Nasdaq Global Select Market	USA
Aptorum Group Limited APM	$ 3.14	1.95 %	$ 13.1 M	Nasdaq Global Select Market	China
Kiromic BioPharma KRBP	$ 3.15	6.61 %	$ 3.08 M	Nasdaq Global Select Market	USA
Trillium Therapeutics Inc. TRIL	$ 18.44	-	$ 1.94 B	Nasdaq Capital Market	Canada
Celyad Oncology SA CYAD	$ 0.47	-	$ 12.5 M	Nasdaq Global Market	Belgium